Not Yet Recruiting EARLY_PHASE1 INTERVENTIONAL 2-arm NCT06089395

The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)

A Randomized and Double-blind Clinical Trial of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response

Sponsor: Capital Medical University

Conditions Poor Ovarian Response

Interventions Jiajian Guishen granules coenzyme Q10

Updated 6 times since 2023 Last updated: Apr 30, 2024 Started: Jun 1, 2024 Primary completion: Aug 31, 2025 Completion: Aug 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Poor Ovarian Response, this trial is actively recruiting participants. The trial is conducted by Capital Medical University and has accumulated 6 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1
Jun 2024 — Jul 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1

Status: Recruiting → Not Yet Recruiting
May 2024 — Jun 2024 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Feb 2024 — May 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1

▶ Show 1 earlier version

Nov 2023 — Feb 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Capital Medical University
Shi Yun

Data source: Dongzhimen Hospital, Beijing

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China